Onesource Specialty Pharma (OSPL) said that India Ratings and Research has upgraded the company’s long-term rating to ‘IND A’ from ‘IND A-‘ with a ‘positive’ outlook.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.
